Skip to main content

Published locations for Aspirin not the best antiplatelet for CAD secondary prevention in meta-analysis

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Aspirin not the best antiplatelet for CAD secondary prevention in meta-analysis

User login

  • Reset your password
  • /content/aspirin-not-best-antiplatelet-cad-secondary-prevention-meta-analysis
  • /clinicianreviews/article/264138/preventive-care/aspirin-not-best-antiplatelet-cad-secondary
  • /familypracticenews/article/264138/preventive-care/aspirin-not-best-antiplatelet-cad-secondary
  • /fedprac/article/264138/preventive-care/aspirin-not-best-antiplatelet-cad-secondary-prevention-meta
  • /internalmedicinenews/article/264138/preventive-care/aspirin-not-best-antiplatelet-cad-secondary
  • /ecardiologynews/article/264138/preventive-care/aspirin-not-best-antiplatelet-cad-secondary
  • /cardiology/article/264138/preventive-care/aspirin-not-best-antiplatelet-cad-secondary-prevention
  • /internalmedicine/article/264138/preventive-care/aspirin-not-best-antiplatelet-cad-secondary
  • /familymedicine/article/264138/preventive-care/aspirin-not-best-antiplatelet-cad-secondary-prevention